Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis

Blood Purification

Volumn 22, Issue 6, 2004, Pages 499-504

  Nakamura, Tsukasa ^a   Kawagoe, Yasuhiko ^a   Matsuda, Takaharu ^a   Ueda, Akiko ^a   Ueda, Yoshihiko ^b   Takahashi, Yutaka ^c   Araki, Tanaka ^c   Koide, Hikaru ^c  

^a Shinmatsudo Central General Hospital   (Japan)

^b DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

Endothelin; Granulocyte and monocyte adsorption; Microalbuminuria; Ulcerative colitis

Indexed keywords

ALBUMIN; ENDOTHELIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DATA ANALYSIS; FEMALE; FLOW RATE; GRANULOCYTE; HOSPITAL PERSONNEL; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL; ULCERATIVE COLITIS; VOLUNTEER;

ADSORPTION; ADULT; ALBUMINURIA; COLITIS, ULCERATIVE; CREATININE; DEFECATION; ENDOTHELIN-1; FEMALE; GRANULOCYTES; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11244329011     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081896     Document Type: Article

References (32)

1. Head KA, Jurenka JS: Inflammatory bowel disease. I. Ulcerative colitis - pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003;8:247-283.
2. Stehouwer CDA, Lambert J, Donker AJM, Van Hinsberg VWM: Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997;34:55-68.
3. Nakamura T, Ushiyama C, Hirokawa K, Osada S, Shimada N, Koide H: Effect of cerivastatin on urinary albumin excretion and plasma endothelin-1 concentrations in type 2 diabetes patients with microalbuminuria and dyslipidemia. Am J Nephrol 2001;21:449-454.
4. Mahmud N, Stinson J, O'Connell MA, Mantle TJ, Keeling PW, Feely J, Weir DG, Kelleher D: Microalbuminuria in inflammatory bowel disease. Gut 1994;35:1599-1604.
5. Mahmud N, O'Connell MA, Stinson J, Goggins MG, Weir DG, Kelleher D: Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:215-219.
6. Nakamura T, Ushiyama C, Suzuki S, Shoji H, Shimada N, Ebihara I, Koide H: Polymyxin B-immobilized fiber reduces increased plasma endothelin-1 concentrations in hemodialysis patients with sepsis. Ren Fail 2000;22:225-234.
7. Nakamura T, Suzuki S, Ushiyama C, Shimada N, Koide H: Effect of phosphodiesterase III inhibitor on plasma concentrations of endothelin-1 and tumour necrosis factor in patients with acute heart failure. Acta Cardiol 2002;57:19-21.
8. Letizia C, Boirivant M, De Toma G, Cerci S, Subioli S, Scuro L, Ferrari P, Pallone F: Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis. Ital J Gastroenterol Hepatol 1998;30:266-269.
9. Rembacken BJ, Newbould HE, Richards SJ, Misbah SA, Dixon ME, Chalmers DM, Axon AT: Granulocyte apheresis in inflammatory bowel disease: Possible mechanisms of effect. Ther Apher 1998;2:93-96.
10. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR: Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study. J Clin Apheresis 2001;16:1-9.
11. Nagashima M, Yoshino S, Tanaka H, Yoshida N, Kashiwagi N, Saniabadi AR: Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: A pilot study. Rheumatol Int 1998;18:113-118.
12. Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. BMJ 1989;298:82-86.
13. Meyer S, Sachur DB, Present DH, Tanowitz HD: Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: A prospective, randomized, placebo controlled double blind, dose-ranging clinical trial. Scand J Gastroenterol 1988;23(suppl 148):29-35.
14. Dezier JF, Le Reun M, Poirier JY: Value of the urinary albumin/creatinine ratio in the detection of microalbuminuria. Presse Med 1988;17:897-900.
15. De Gaudio AR, Spina R, Di Filippo A, Feri M: Glomerular permeability and trauma: A correlation between microalbuminuria and Injury Severity Score. Crit Care Med 1999;27:2105-2108.
16. Hasegawa M, Kawamura N, Kasugai M, Koide S, Murase M, Asano S, Toba T, Kushimoto H, Murakami K, Tomita M, Shikano M, Sugiyama S: Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis: Report of five cases. Ther Apher 2002;6:443-449.
17. Das KM: Relationship of extraintestinal involvements in inflammatory bowel disease: New insights into autoimmune pathogenesis. Dig Dis Sci 1999;44:1-13.
18. Osangthamnont C, Manatsathit S, Pongprasopchai S, Viriyataveekul R, Chaihirunkarn S, Leelakusolvong S, Boonyapisit S: Antibodies to neutrophil cytoplasm in patients with ulcerative colitis and their first-degree relatives in Thailand. J Gastroenterol Hepatol 2001;16:866-871.
19. Cabral VL, Miszputen SJ, Catapani WR: Antineutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease. Hepatogastroenterology 2003;50:412-415.
20. Gionchetti P, Vecchi M, Rizzello F, Ferretti M, Calabresi C, Venturi A, Bianchi MB, Brignola C, Sinico RA, De Franchis R, Miglioli M, Campieri M: Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils. Gut 1997;40:102-104.
21. Rosa M, Esposito C, Caglioti A, Mazza G, Capria M, Comi N, Monteleone G, Sinico RA, Fuiano G: Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement? Nephrol Dial Transplant 1996;11:2426-2429.
22. Rodicio JL, Campo C, Ruilope LM: Microalbuminuria in essential hypertension. Kidney Int Suppl 1998;68:S51-S54.
23. Gosling P, Sanghera K, Dickson G: Generalized vascular permeability and pulmonary function in patients following serious trauma. J Trauma 1994;36:477-481.
24. Gosling P: Microalbuminuria: A marker of systemic disease. Br J Hosp Med 1995;54:285-290.
25. Mahmud N, McDonald GS, Kelleher D, Weir DG: Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut 1996;38:99-103.
26. Griga T, Tromm A, Spranger J, May B: Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:504-508.
27. Grone HJ, Simon M, Grone EF: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 1995;177:259-267.
28. Unemori EN, Ferrara N, Bauer EA, Amento EP: Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992;153:557-562.
29. Murch SH, Braegger CP, Sessa WC, MacDonald TT: High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis. Lancet 1992;339:381-385.
30. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K: VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: A novel mechanism of chronic interstitial inflammation. Am J Gastroenterol 2001;96:822-828.
31. Padol I, Huang JQ, Hogaboam CM, Hunt RH: Therapeutic effects of the endothelin receptor antagonist Ro 48-5695 in the TNBS/DNBS rat model of colitis. Eur J Gastroenterol Hepatol 2000;12:257-265.
32. Tsukada Y, Nakama T, Iimura M, Iizuka B, Hayashi N: Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocyte apheresis. Am J Gastroenterol 2002;97:2820-2828.